SHCSP、AFP用于肝癌检测的评价  

Assessment of Determination of Hepatocellular Carcinoma by SHCSP and AFP

作　　者：杨峰[1] 赵维华[1] 

机构地区：[1]湖北省肿瘤医院,武汉市430079

出　　处：《陕西医学检验》2000年第3期51-52,共2页Shaanxi Journal of Medical Laboratory Sciences

摘　　要：报道 1 2 334例不同人群组的 SHCSP检测结果 :原发性肝癌 SHCSP法阳性检出率 ( 90 .8% )高于AFP检出率 ( 75.7% )。转移性肝癌 SHCSP阳性检出率 80 .4% ,提示对肝外恶性肿瘤的肝转移有检测意义。对非肝癌组其他人群 SHCSP阳性者的追踪观察的结果显示 ,SHCSP对发现早期肝癌意义重大。The total of 12 334 Cases from different groups were detected by SHCSP test.The results indicated the positive rate of SHCSP test (90 8%)wad high to that of AFP test (75 7%)in Hepatocellular Carcinoma.In metastasis liver Cancer.the positive rate of SHCSPtest accounts for 80 4%.The results suggest the SHSCP test has determinate significance in liver metastasis of the other cancer.Follow up the positive cases in non Hepatocellular Carcinoma groups,it showed that SHCSP may be used for detected early stage liver cancer.

关 键 词：血清肝癌特异蛋白 原发性肝癌 转移性肝癌 

分 类 号：R735.7[医药卫生—肿瘤]